Carrie T Freeman is the Chief Executive Officer of Eden Radioisotopes, where she is focused on advancing the development of North America's first purpose-built medical isotope reactor. This initiative aims to secure a domestic isotope supply for nuclear medicine, addressing a critical need for modern healthcare.

With more than two decades of experience, Freeman has led high-growth companies, mobilized billions in capital, and built ventures and partnerships across over 160 countries.